CHICAGO — Patients with metabolic syndrome are at risk for developing HF with preserved ejection fraction, although the mechanisms behind this risk are speculative at the moment, according to a presentation at the Cardiometabolic Health Congress.
As HFpEF becomes more understood, cardiologists see that several comorbid conditions are involved in the development of HFpEF such as systemic microvascular endothelial inflammation, vascular oxidative stress and secondary fibrosis.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.